Lupin
5 federal recalls on file. We monitor every CPSC, FDA, USDA, and NHTSA notice for Lupin and translate it into plain English — free weekly digest, optional same-day alerts.
- 2026-07-08FDA-DrugClass IILupin prednisolone acetate eye drops recalled for foreign substance
Lupin Pharmaceuticals is recalling multiple lots of prednisolone acetate ophthalmic suspension 1% (an anti-inflammatory eye drop) due to the presence of a foreign substance in some bottles. The affected lots were distributed nationwide. No injuries have been reported.
- 2026-07-08FDA-DrugNot Yet ClassifiedLupin Glucagon Emergency Kit recalled for plunger defect
Lupin Pharmaceuticals is recalling certain lots of its Glucagon Emergency Kit because the syringe plunger may not move smoothly during use. This defect was discovered during stability testing and could prevent the kit from working properly in an emergency.
- 2026-05-27FDA-DrugClass IILupin Liraglutide Injection recalled for particulate matter
Lupin Pharmaceuticals is recalling certain batches of Liraglutide Injection (a diabetes and weight-loss medication) because white thread-like particles have been found inside the cartridges. The affected pens are distributed nationwide. No injuries have been reported.
- 2025-12-17FDA-DrugClass IISertraline Hydrochloride Tablets USP, 100 mg, 90 Tablets bottles, Rx Only, Manufactured by: Lupin Pharmaceuticals, Inc., Naples, FL 34108, NDC 68180-353-09.
Defective container - seal not adhering to bottles
- 2025-12-17FDA-DrugClass IIGanirelix Acetate Injection, 250 mcg/0.5mL, Single-dose Sterile Prefilled Syringe, 27 gauge by 1/2' needle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Naples, FL 34108, United States, Manufactured by: Lupin Limited, Nagpur - 441108, INDIA, NDC 70748-274-01
Failed impurities/degradation specifications: out of specification results for Ganirelix acetate acrylic acid adduct impurity.
Get notified about new Lupin recalls
Free weekly digest. We email when a new federal recall affects Lupin or anything else in your household.
Get the Sunday Brief